基于专利申请视角的我国医药企业创新投入产出分析
x
请在关注微信后,向客服人员索取文件
篇名: | 基于专利申请视角的我国医药企业创新投入产出分析 |
TITLE: | Analysis on Innovation Input-output in China ’s Pharmaceutical Enterprises from the Perspective of Patent Appli- cation |
摘要: | 目的:为我国医药企业优化资源配置和精准投入提供依据。方法:检索中国知识产权网中我国医药行业发明专利申请数量,分析我国医药行业专利申请主体的现状及结构。运用SPSS23.0软件对我国医药企业发明专利申请数量与其研发经费投入情况及主营业务收入进行投入产出的相关性分析。结果:我国医药行业发明专利申请量逐年递增,2000-2015年在我国申请医药领域发明专利的国内申请主体共申请发明专利225861件,国外申请主体共申请发明专利43149件;国内申请主体的职务发明比例仅为49.94%,国外申请主体的职务发明比例为96.79%。我国医药企业研发经费投入与其发明专利申请数量之间呈正相关,表明我国医药行业的研发投入有利于促进发明专利的申请;医药企业主营业务收入与医药企业发明专利申请数量亦呈正相关,表明医药企业发明专利申请数量的增加有效扩大了医药行业的经济规模。结论:我国医药行业发明专利主体的结构与国外相比亟待调整,医药企业尚未成为发明专利的主要申请主体;医药企业持续的研发经费投入有效促进了发明专利的申请,扩大了医药行业的经济规模。 |
ABSTRACT: | OBJECTIVE:To provide reference for optimizing resource allocation and precise investment of China ’s pharma- ceutical industry. METHODS :The number of invention patent applications in China ’s pharmaceutical industry was searched from China Intellectual Property Netwerk ,and the status quo and structure of patent applications in China ’s pharmaceutical industry were analyzed. SPSS 23.0 software was used to analyze the input-output correlation of the number of invention patent applications with R&D investment and main business income of pharmaceutical enterprises in China. RESULTS :The number of invention patent applications in China ’s pharmaceutical industry increased year by year. From 2000 to 2015,225 861 invention patents had been applied by domestic applicants and 43 149 invention patents had been applied by foreign applicants in China ;only 49.94% domestic applicants applied for professional invention ,while 96.79% of foreign applicants applied for professional invention. There was a positive correlation between the R&D expenditure of pharmaceutical enterprises and the number of invention patent applications,which indicated that the R&D investment of pharmaceutical industry in China was beneficial to the invention patent applications. The number of invention patent applications of pharmaceutical enterprises was also positively correlated with the main business income ,indicating that the increase of invention patent applications of pharmaceutical enterprises also effectively expanded the economic scale of pharmaceutical industry. CONCLUSIONS :Compared with foreign countries ,the structure of patent applicants in domestic pharmaceutical industry needs to be adjusted urgently. Pharmaceutical enterprises have not yet become the main applicants. The continuous R&D investment of pharmaceutical enterprises effectively promotes the application of invention patent,expanded the economic scale of the pharmaceutical industry. |
期刊: | 2020年第31卷第02期 |
作者: | 杨舒杰,武志昂 |
AUTHORS: | YANG Shujie,WU Zhi ’ang |
关键字: | 发明专利;专利申请;医药企业;投入产出;研发 |
KEYWORDS: | Invention patent ;Patent application ;Pharmaceutical enterprise ;Input-output;R&D |
阅读数: | 539 次 |
本月下载数: | 11 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!